IP Library Granted Patent US 8,236,814
Granted Patent B2
US 8,236,814 · App. 12/559,148 · Granted Aug 7, 2012

Composition and method for treatment of warts

Assignee: NuCara Pharmaceutical, L.C.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,236,814
App. No.
12/559,148
Granted
Aug 7, 2012
Kind
B2
Abstract

Provided is a composition comprising 5-FU and salicylic acid. This composition is useful as a treatment for warts. As opposed to conventional compositions and methods, this composition need only be applied once a day. Also provided are methods for the preparation and use of the composition for treatment of warts.

Claims (16)

1. A method of treating warts comprising: topically applying to a wart a therapeutically effective amount of a composition consisting essentially of from about 2-5% by weight 5-fluorouracil (5-FU), from about 10-25% by weight salicylic acid, from about 5-50% by weight organic solvent, said organic solvent being first combined with the 5-FU so as to dissolve the 5-FU followed by addition of salicylic acid followed by other ingredients of the composition; from about 1-10% by weight water-swellable polymer; and an adhesive; and allowing the composition to release salicylic acid onto the wart to remove keratin from the wart and surrounding skin to allow penetration of the 5-FU into the wart.

2. The method of claim 1 whereby the composition is applied once daily.

3. The method of claim 2 whereby the composition is applied at about the same time each day.

4. The method of claim 2 whereby the composition is applied at bedtime.

5. The method of claim 1 whereby the composition is occluded following application.

6. The method of claim 5 whereby the composition is occluded through application of a device selected from the group consisting of bandages, plastic wrap, and adhesive tape.

7. The method of claim 1 whereby the composition is applied to the wart for a time period of at least one week.

8. The method of claim 1 whereby the composition is applied at bedtime.

9. The method of claim 1 whereby the composition is a sustained release topical gel.

10. The method of claim 1 whereby the composition is applied to the wart using an applicator.

11. The method of claim 10 whereby the applicator is selected from the group consisting of swab, sponge, finger cot, and toothpick.

12. The method of claim 9 whereby the composition is applied using the side of a flat toothpick to “frost” the wart.

13. The method of claim 1 further including the step of washing the wart prior to the application step.

14. The method of claim 1 whereby the composition is applied to the wart for at least seven days.

15. The method of claim 1 whereby the composition is applied to the wart daily until the patient can no longer visualize the wart.

16. A method of treating warts comprising: topically applying to a wart a therapeutically effective amount of a composition consisting essentially of from about 2-5% by weight 5-fluorouracil (5-FU), from about 10-25% by weight salicylic acid, from about 5-50% by weight DMSO; from about 1-10% by weight water-swellable polymer; and an adhesive; and allowing the composition to release salicylic acid onto the wart to remove keratin from the wart and surrounding skin to allow penetration of the 5-FU into the wart.

Assignments (2)
CHANGE OF NAME Recorded Sep 2, 2011
From: NUCARA PHARMACEUTICAL, L.LC.
To: MEDCARA, L.L.C.
Reel/Frame 026855/0487 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2011
From: HERMAN, CRAIG
To: NUCARA PHARMACEUTICAL, L.C.
Reel/Frame 026842/0515 →
Continuity (2)
Division 11037403 · Jan 18, 2005
Related Publication 20100003325A1 · Jan 7, 2010